Source: International Journal of Gastrointestinal Cancer. Unidade: FM
Subjects: NEOPLASIAS PANCREÁTICAS (QUIMIOTERAPIA), ESTADIAMENTO DE NEOPLASIAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAAD, Everardo D. et al. Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International Journal of Gastrointestinal Cancer, v. 32, n. 1, p. 35-41, 2002Tradução . . Acesso em: 21 maio 2024.APA
Saad, E. D., Machado, M. C., Wajsbrot, D., Abramoff, R., Hoff, P. M., Tabacof, J., et al. (2002). Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International Journal of Gastrointestinal Cancer, 32( 1), 35-41.NLM
Saad ED, Machado MC, Wajsbrot D, Abramoff R, Hoff PM, Tabacof J, Katz A, Simon SD, Gansl RC. Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International Journal of Gastrointestinal Cancer. 2002 ; 32( 1): 35-41.[citado 2024 maio 21 ]Vancouver
Saad ED, Machado MC, Wajsbrot D, Abramoff R, Hoff PM, Tabacof J, Katz A, Simon SD, Gansl RC. Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International Journal of Gastrointestinal Cancer. 2002 ; 32( 1): 35-41.[citado 2024 maio 21 ]